相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice
Beatriz Carmona-Hidalgo et al.
PHYTOMEDICINE (2021)
Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments
Marco Aurelio Mori et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol
Gemma Navarro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco et al.
PHARMACOLOGICAL RESEARCH (2020)
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
Gemma Navarro et al.
PHARMACOLOGICAL RESEARCH (2020)
Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor**
Paula Morales et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Expression of GPR55 and either cannabinoid CB1or CB2heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates
Eva Martinez-Pinilla et al.
BRAIN STRUCTURE & FUNCTION (2020)
Diversity of molecular targets and signaling pathways for CBD
Douglas L. de Almeida et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage
Rafael Franco et al.
NEUROPHARMACOLOGY (2019)
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
Gemma Navarro et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
Gemma Navarro et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Emerging strategies targeting CB2 cannabinoid receptor: Biased agonism and allosterism
Paula Morales et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
Maria Ceprian et al.
NEUROPHARMACOLOGY (2017)
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
Eva Martinez-Pinilla et al.
FRONTIERS IN PHARMACOLOGY (2017)
Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice
Nagat Mohammed et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis
Paula Morales et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
Gemma Navarro et al.
FRONTIERS IN NEUROSCIENCE (2016)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice
Simona Bertoni et al.
PHARMACOLOGICAL RESEARCH (2014)
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Javier Fernandez-Ruiz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors
M. Ruth Pazos et al.
NEUROPHARMACOLOGY (2013)
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Lucia Callen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
M. R. Pazos et al.
NEUROPHARMACOLOGY (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
NCS-1 associates with adenosine A(2A) receptors and modulates receptor function
Gemma Navarro et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Prospects for cannabinoid therapies in basal ganglia disorders
Javier Fernandez-Ruiz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Post-translational Membrane Insertion of Tail-anchored Transmembrane EF-hand Ca2+ Sensor Calneurons Requires the TRC40/Asna1 Protein Chaperone
Johannes Hradsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cannabidiol Reduces Brain Damage and Improves Functional Recovery After Acute Hypoxia-Ischemia in Newborn Pigs
Hector Lafuente et al.
PEDIATRIC RESEARCH (2011)
Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
S. E. O'Sullivan et al.
IMMUNOBIOLOGY (2010)
Therapeutic Time Window of Cannabidiol Treatment on Delayed Ischemic Damage via High-Mobility Group Box1-Inhibiting Mechanism
Kazuhide Hayakawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Javier Palazuelos et al.
BRAIN (2009)
Building a new conceptual framework for receptor heteromers
Sergi Ferre et al.
NATURE CHEMICAL BIOLOGY (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
G-protein-coupled receptor heteromers:: function and ligand pharmacology
R. Franco et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Detection of heteromerization of more than two proteins by sequential BRET-FRET
Paulina Carriba et al.
NATURE METHODS (2008)
Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
Francisco J. Alvarez et al.
PEDIATRIC RESEARCH (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Intramembrane receptor-receptor interactions: a novel principle in molecular medicine
K. Fuxe et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism
K Mishima et al.
STROKE (2005)
分享论文
